Wp Advisors, LLC Abb Vie Inc. Transaction History

Wp Advisors, LLC

$273 Million
Q3 2024

A detailed history of Wp Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wp Advisors, LLC holds 33,415 shares of ABBV stock, worth $5.87 Million. This represents 2.41% of its overall portfolio holdings.

Number of Shares

33,415

Previous 35,481 5.82%

Holding current value

$5.87 Million

Previous $6.09 Million 8.43%

% of portfolio

2.41%

Previous 1.93%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$163.84 - $199.33 $338,493 - $411,815	-2,066 Reduced 5.82%	33,415 $6.6 Million
Q2 2024 Jul 30, 2024	SELL	$154.79 - $180.76 $17,491 - $20,425	-113 Reduced 0.32%	35,481 $6.09 Million
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $23,173 - $26,404	-145 Reduced 0.41%	35,594 $6.48 Million
Q4 2023 Jan 31, 2024	SELL	$137.6 - $154.97 $33,436 - $37,657	-243 Reduced 0.68%	35,739 $5.54 Million
Q3 2023 Oct 30, 2023	BUY	$133.59 - $154.65 $39,409 - $45,621	295 Added 0.83%	35,982 $5.36 Million
Q2 2023 Jul 26, 2023	SELL	$132.51 - $164.9 $102,695 - $127,797	-775 Reduced 2.13%	35,687 $4.81 Million
Q1 2023 Apr 14, 2023	BUY	$144.61 - $166.54 $22,125 - $25,480	153 Added 0.42%	36,462 $5.81 Million
Q4 2022 Jan 20, 2023	SELL	$138.31 - $165.87 $46,333 - $55,566	-335 Reduced 0.91%	36,309 $0
Q3 2022 Oct 24, 2022	BUY	$134.21 - $153.93 $59,589 - $68,344	444 Added 1.23%	36,644 $4.92 Million
Q2 2022 Jul 12, 2022	BUY	$137.62 - $174.96 $11,147 - $14,171	81 Added 0.22%	36,200 $5.54 Million
Q1 2022 Apr 25, 2022	SELL	$131.98 - $163.75 $184,772 - $229,250	-1,400 Reduced 3.73%	36,119 $5.86 Million
Q4 2021 Feb 02, 2022	SELL	$107.43 - $135.93 $23,742 - $30,040	-221 Reduced 0.59%	37,519 $5.08 Million
Q3 2021 Oct 20, 2021	SELL	$106.4 - $120.78 $46,496 - $52,780	-437 Reduced 1.14%	37,740 $4.07 Million
Q2 2021 Jul 22, 2021	SELL	$105.21 - $117.21 $30,931 - $34,459	-294 Reduced 0.76%	38,177 $4.3 Million
Q1 2021 May 06, 2021	BUY	$102.3 - $112.62 $142,606 - $156,992	1,394 Added 3.76%	38,471 $4.16 Million
Q4 2020 Jan 27, 2021	BUY	$80.49 - $108.67 $24,790 - $33,470	308 Added 0.84%	37,077 $3.97 Million
Q3 2020 Oct 16, 2020	BUY	$85.91 - $100.83 $610,218 - $716,195	7,103 Added 23.94%	36,769 $3.22 Million
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $95,601 - $127,928	1,303 Added 4.59%	29,666 $2.91 Million
Q1 2020 Apr 29, 2020	SELL	$64.5 - $97.79 $14,190 - $21,513	-220 Reduced 0.77%	28,363 $2.16 Million
Q4 2019 Jan 22, 2020	SELL	$72.13 - $90.25 $83,815 - $104,870	-1,162 Reduced 3.91%	28,583 $2.53 Million
Q3 2019 Oct 22, 2019	SELL	$62.98 - $75.72 $282,780 - $339,982	-4,490 Reduced 13.12%	29,745 $2.25 Million
Q2 2019 Jul 23, 2019	BUY	$65.7 - $83.98 $130,151 - $166,364	1,981 Added 6.14%	34,235 $2.49 Million
Q1 2019 Apr 15, 2019	BUY	$77.14 - $90.79 $7,096 - $8,352	92 Added 0.29%	32,254 $26 Million
Q4 2018 Jan 18, 2019	SELL	$77.85 - $96.01 $24,367 - $30,051	-313 Reduced 0.96%	32,162 $2.97 Million
Q3 2018 Oct 31, 2018	SELL	$88.91 - $98.84 $37,697 - $41,908	-424 Reduced 1.29%	32,475 $3.07 Million
Q2 2018 Jul 27, 2018	BUY	$89.78 - $106.23 $17,237 - $20,396	192 Added 0.59%	32,899 $3.05 Million
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $496,854 - $665,334	-5,400 Reduced 14.17%	32,707 $3.1 Million
Q4 2017 Feb 05, 2018	SELL	$89.56 - $98.21 $237,065 - $259,961	-2,647 Reduced 6.5%	38,107 $3.69 Million
Q3 2017 Nov 02, 2017	SELL	$69.85 - $89.22 $29,825 - $38,096	-427 Reduced 1.04%	40,754 $3.62 Million
Q2 2017 Aug 08, 2017	BUY	N/A	41,181	41,181 $2.99 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wp Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wp Advisors, LLC with notifications on news.

Account